Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy

Overview of attention for article published in Immunobiology, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#20 of 1,454)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs: 1 blog
twitter: 4 X users

patent: 4 patents
facebook: 1 Facebook page

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 4 patents that reference this research output.

Compstatin analogues and their medical uses

Grant US-12600749-B2

United States of America

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

Application EP-4585228-A3

European Patent Office

Compstatin analogs and medical uses thereof

Application CN-112041330-A

China

POLYPEPTIDES FOR THE DIAGNOSIS AND THE TREATMENT OF C3 NEF ASSOCIATED C3 GLOMERULOPATHY

Application WO-2016203021-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.